Report Hungary - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Sep 15, 2022

Hungary - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Pricing Plan

You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).

By clicking «Buy the Report», you agree to our Terms of Service, Privacy Policy and Licenses. We'll occasionally send you account related emails.

Hungary: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2022

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Hungary

The Hungarian prophylactic medicaments containing insulin market declined modestly to $X in 2021, falling by -X% against the previous year. Over the period under review, the total consumption indicated prominent growth from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +X% against 2012 indices. Prophylactic medicaments containing insulin consumption peaked at $X in 2020, and then declined modestly in the following year.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Hungary

In value terms, prophylactic medicaments containing insulin production shrank modestly to $X in 2021 estimated in export price. In general, the total production indicated a strong increase from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +X% against 2012 indices. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. Over the period under review, production attained the maximum level at $X in 2020, and then contracted in the following year.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Hungary

In 2021, exports of medicaments containing insulin but not antibiotics in measured doses from Hungary soared to X tons, rising by X% on the previous year. In general, total exports indicated a tangible increase from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +X% against 2016 indices. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports skyrocketed to $X in 2021. Overall, total exports indicated a strong increase from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +X% against 2016 indices. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

Romania (X tons) was the main destination for prophylactic medicaments containing insulin exports from Hungary, with a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Romania exceeded the volume sent to the second major destination, Slovenia (X tons), fivefold. The third position in this ranking was held by Lithuania (X tons), with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of volume to Romania amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Slovenia (+X% per year) and Lithuania (+X% per year).

In value terms, Romania ($X) remains the key foreign market for prophylactic medicaments containing insulin exports from Hungary, comprising X% of total exports. The second position in the ranking was held by Lithuania ($X), with an X% share of total exports. It was followed by Ukraine, with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of value to Romania stood at +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Lithuania (+X% per year) and Ukraine (+X% per year).

Export Prices by Country

In 2021, the average prophylactic medicaments containing insulin export price amounted to $X per ton, with an increase of X% against the previous year. Over the last nine years, it increased at an average annual rate of +X%. The most prominent rate of growth was recorded in 2016 when the average export price increased by X%. Over the period under review, the average export prices attained the peak figure in 2021 and is likely to see gradual growth in the immediate term.

There were significant differences in the average prices for the major foreign markets. In 2021, the country with the highest price was Croatia ($X per ton), while the average price for exports to Uzbekistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Georgia (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Hungary

In 2021, supplies from abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -X% to X tons for the first time since 2013, thus ending a seven-year rising trend. Overall, imports, however, showed a strong expansion. The pace of growth was the most pronounced in 2014 when imports increased by X% against the previous year. Imports peaked at X tons in 2020, and then declined in the following year.

In value terms, prophylactic medicaments containing insulin imports dropped to $X in 2021. The total import value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2017 when imports increased by X% against the previous year. Over the period under review, imports hit record highs at $X in 2020, and then dropped in the following year.

Imports by Country

Germany (X tons), France (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Hungary, together accounting for X% of total imports.

From 2012 to 2021, the biggest increases were in France (with a CAGR of +X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), France ($X) and Denmark ($X) constituted the largest prophylactic medicaments containing insulin suppliers to Hungary, together comprising X% of total imports.

In terms of the main suppliers, France, with a CAGR of +X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2021, approximately equating the previous year. In general, the import price, however, continues to indicate a pronounced descent. The pace of growth was the most pronounced in 2013 an increase of X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2014 to 2021, the average import prices remained at a lower figure.

Prices varied noticeably countryorigin: the country with the highest price was Denmark ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Germany (-X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in measured doses in the world?
+
The countries with the highest volumes of prophylactic medicaments containing insulin consumption in 2021 were China, the United States and India, with a combined 52% share of global consumption.
What are the largest producers of medicaments containing insulin but not antibiotics in measured doses in the world?
+
The countries with the highest volumes of prophylactic medicaments containing insulin production in 2021 were China, the United States and India, together accounting for 52% of global production.
What are the leading suppliers of medicaments containing insulin but not antibiotics in measured doses to Hungary?
+
In value terms, the largest prophylactic medicaments containing insulin suppliers to Hungary were Germany, France and Denmark, together accounting for 99% of total imports.
What are the leading importers of medicaments containing insulin but not antibiotics in measured doses from Hungary?
+
In value terms, Romania remains the key foreign market for prophylactic medicaments containing insulin exports from Hungary, comprising 36% of total exports. The second position in the ranking was taken by Lithuania, with an 8% share of total exports. It was followed by Ukraine, with a 7.8% share.
What is the average export price for medicaments containing insulin but not antibiotics in measured doses in Hungary?
+
In 2021, the average prophylactic medicaments containing insulin export price amounted to $195,604 per ton, with an increase of 11% against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in measured doses in Hungary?
+
In 2021, the average prophylactic medicaments containing insulin import price amounted to $213,886 per ton, stabilizing at the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Hungary. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
• Hungary

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in Hungary
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCTS

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption In 2012–2021
Table 5:
Imports, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Value Terms, By Country, 2012–2021
Table 7:
Import Prices, By Country Of Origin, 2012–2021
Table 8:
Exports, In Physical Terms, By Country, 2012–2021
Table 9:
Exports, In Value Terms, By Country, 2012–2021
Table 10:
Export Prices, By Country Of Destination, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012–2021
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012–2021
Figure 5:
Trade Balance, In Physical Terms, 2012–2021
Figure 6:
Trade Balance, In Value Terms, 2012–2021
Figure 7:
Per Capita Consumption, 2012–2021
Figure 8:
Market Forecast To 2030
Figure 9:
Products: Market Size And Growth, By Type
Figure 10:
Products: Average Per Capita Consumption, By Type
Figure 11:
Products: Exports And Growth, By Type
Figure 12:
Products: Export Prices And Growth, By Type
Figure 13:
Production Volume And Growth
Figure 14:
Exports And Growth
Figure 15:
Export Prices And Growth
Figure 16:
Market Size And Growth
Figure 17:
Per Capita Consumption
Figure 18:
Imports And Growth
Figure 19:
Import Prices
Figure 20:
Production, In Physical Terms, 2012–2021
Figure 21:
Production, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, 2012–2021
Figure 23:
Imports, In Value Terms, 2012–2021
Figure 24:
Imports, In Physical Terms, By Country, 2021
Figure 25:
Imports, In Physical Terms, By Country, 2012–2021
Figure 26:
Imports, In Value Terms, By Country, 2012–2021
Figure 27:
Import Prices, By Country Of Origin, 2012–2021
Figure 28:
Exports, In Physical Terms, 2012–2021
Figure 29:
Exports, In Value Terms, 2012–2021
Figure 30:
Exports, In Physical Terms, By Country, 2021
Figure 31:
Exports, In Physical Terms, By Country, 2012–2021
Figure 32:
Exports, In Value Terms, By Country, 2012–2021
Figure 33:
Export Prices, By Country Of Destination, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET